Germany has granted its first license for the domestic cultivation of medical cannabis to Berlin-based company Creso Pharma. The company plans to cultivate a variety of cannabis strains for use in medical products, including extracts, oils, and tinctures. That’s an exciting development for the medicinal cannabis industry in Germany. The approval of the first domestic cultivation license for medical cannabis marks a significant step forward in establishing a regulated and sustainable supply of high-quality cannabis products for German patients. This move will likely have a positive impact on the availability and affordability of medical cannabis in Germany, making it more accessible to those who need it.

Creso Pharma’s plans to cultivate a variety of cannabis strains for use in medical products is also noteworthy. This diversification will allow the company to cater to the diverse needs of patients with a range of medical conditions. The development of extracts, oils, and tinctures will provide patients with more options in choosing the form of cannabis that best suits their individual needs and preferences.

Overall, the approval of Creso Pharma’s cultivation license is a positive development for the medicinal cannabis industry in Germany. It signals the country’s commitment to providing patients with safe and effective access to medical cannabis products.

• Germany Approves First Domestic Medical Cannabis Cultivation License (November 30, 2023) – Source: Prohibition Partners

the approval of the first domestic cultivation license for medical cannabis in Germany to Berlin-based company Creso Pharma is a significant development. This will likely enhance the availability and affordability of medical cannabis for German patients¹.

Creso Pharma’s plan to cultivate a variety of cannabis strains for use in medical products, including extracts, oils, and tinctures, is a noteworthy move. It will cater to the diverse needs of patients with various medical conditions¹.

This development signals Germany’s commitment to providing patients with safe and effective access to medical cannabis products¹. It’s a positive step for the medicinal cannabis industry in Germany¹.

For more details, you can refer to the source: Prohibition Partners.

Learn more:

1. internationalcbc.com2. internationalcbc.com3. theguardian.com4. labiotech.eu5. prnewswire.com6. cannabishealthnews.co.uk